乌鸦传媒

<乌鸦传媒 class="page-title">Endocrinology

Growth Disorders

<乌鸦传媒 class="page-description">

More in Growth Disorders

Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon

News and commentary from the endocrinology world

Dec 17, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Experts Wrestle Over Uses of PFAS During Senate Hearing

Industry witness warns of unintended consequences of blanket bans

Dec 06, 2024
A screenshot of Senator Jeff Merkley speaking during this hearing.
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

News and commentary from the endocrinology world

Dec 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome

News and commentary from the endocrinology world

Nov 26, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
U.S. Towns Plunge Into Debates About Fluoride in Water

"I didn't realize it would be such a heated discussion," says a mayor of one such town

Nov 21, 2024
A photo of residents attending a city council meeting about the fluoridation of the drinking water in Durango, Colorado.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Oral Drug Safe, Effective in Kids With Achondroplasia

No adverse events resulted in treatment discontinuation

Nov 18, 2024
A photo of a group of boys affected by achondroplasia.
Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids

News and commentary from the endocrinology world

Oct 22, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Elamipretide for Barth Syndrome Survives FDA Advisory Vote

Panelists acknowledge difficulty generating stronger data in ultra-rare disease

Oct 11, 2024
FDA ADCOMM elamipretide hydrochloride injection over a computer rendering of mitochondria.
FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndrome

Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease

Oct 09, 2024
FDA ADCOMM elamipretide hydrochloride injection over a computer rendering of mitochondria.
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia

News and commentary from the endocrinology world

Oct 08, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D

News and commentary from the endocrinology world

Oct 01, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics

News and commentary from the endocrinology world

Sep 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available

News and commentary from the endocrinology world

Aug 27, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
More in Growth Disorders

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Beyond Statin Therapy: Evidence-Based Strategies and Advanced Therapeutic Approaches to Hyperlipidemia Management

0.75 CME Credits
Aligning Clinical Practices With the Latest Evidence in Management of Comorbidities and Complications in People With Cystic Fibrosis